Literature DB >> 25896522

Molecular and functional characterization of choline transporter in the human trophoblastic cell line JEG-3 cells.

M Yara1, B Iwao2, N Hara1, T Yamanaka3, H Uchino1, M Inazu4.   

Abstract

INTRODUCTION: Choline is essential for the synthesis of the major membrane phospholipid phosphatidylcholine (PC), the methyl donor betaine and the neurotransmitter acetylcholine (ACh), which is involved in several vital biological functions that play key roles in fetal development. In this study, we examined the molecular and functional characteristics of choline uptake in the human trophoblastic cell line JEG-3.
METHODS: We examined [(3)H]choline uptake in the human trophoblastic cell line JEG-3. The expression of CTL1 and CTL2 was evaluated by quantitative real-time PCR, western blotting and immunocytochemistry.
RESULTS: We demonstrated that JEG-3 cells take up [(3)H] choline by a saturable process that is mediated by a Na(+)-independent and pH-dependent transport system. The cells have two different [(3)H] choline transport systems, high- and low-affinity, with Km values of 28.4 ± 5.0 μM and 210.6 ± 55.1 μM, respectively. Cationic compounds and hemicholinium-3 (HC-3) inhibited choline uptake. Choline transporter-like protein 1 (CTL1) and CTL2 mRNA and protein were highly expressed in JEG-3 cells and were localized to the plasma membrane. DISCUSSION: The present results suggest that choline is mainly transported via a high-affinity choline transport system (CTL1) and a low-affinity choline transport system (CTL2) in human trophoblastic JEG-3 cells. These transporters play an important role in the growth of the fetus.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood placenta barrier; Choline; Choline transporter-like protein; JEG-3 cells; Transporter

Mesh:

Substances:

Year:  2015        PMID: 25896522     DOI: 10.1016/j.placenta.2015.03.010

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

1.  Characterization of choline transporters in the human placenta over gestation.

Authors:  Heidi K Baumgartner; Kinsey M Trinder; Carly E Galimanis; Annalisa Post; Tzu Phang; Randal G Ross; Virginia D Winn
Journal:  Placenta       Date:  2015-10-09       Impact factor: 3.481

2.  Choline Kinase, A Novel Drug Target for the Inhibition of Streptococcus pneumoniae.

Authors:  Tahl Zimmerman; Salam Ibrahim
Journal:  Antibiotics (Basel)       Date:  2017-09-25

3.  Molecular and Functional Analysis of Choline Transporters and Antitumor Effects of Choline Transporter-Like Protein 1 Inhibitors in Human Pancreatic Cancer Cells.

Authors:  Kaho Hirai; Saiichiro Watanabe; Nozomi Nishijima; Kaoru Shibata; Akane Hase; Tsuyoshi Yamanaka; Masato Inazu
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

4.  Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets.

Authors:  Fumiaki Nagashima; Ryohta Nishiyama; Beniko Iwao; Yuiko Kawai; Chikanao Ishii; Tsuyoshi Yamanaka; Hiroyuki Uchino; Masato Inazu
Journal:  Biomol Ther (Seoul)       Date:  2018-07-01       Impact factor: 4.634

5.  Functional Expression of Choline Transporters in Microglia and Their Regulation of Microglial M1/M2 Polarization.

Authors:  Toshio Okada; Eisuke Muto; Tsuyoshi Yamanaka; Hiroyuki Uchino; Masato Inazu
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

Review 6.  Choline and choline-related nutrients in regular and preterm infant growth.

Authors:  Wolfgang Bernhard; Christian F Poets; Axel R Franz
Journal:  Eur J Nutr       Date:  2018-10-08       Impact factor: 5.614

7.  Head-to-head comparison of [18F]-fluorodeoxyglucose and [18F]-fluorocholine positron emission tomography/computed tomography in three patients with rare gestational trophoblastic neoplasms: A case series.

Authors:  Tanyaluck Thientunyakit; Thonnapong Thongpraparn; Tossaporn Siriprapa; Juri G Gelovani
Journal:  World J Nucl Med       Date:  2019-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.